|
1
|
LeSueur BW, DiCaudo DJ and Connolly SM:
Axillary basal cell carcinoma. Dermatol Surg. 29:1105–1108. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Climstein M, Furness J, Hing W and Walsh
J: Lifetime prevalence of non-melanoma and melanoma skin cancer in
Australian recreational and competitive surfers. Photodermatol
Photoimmunol Photomed. 32:207–213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leiter U, Eigentler T and Garbe C:
Epidemiology of skin cancer. Adv Exp Med Biol. 810:120–140.
2014.PubMed/NCBI
|
|
4
|
Lucena SR, Salazar N, Gracia-Cazaña T,
Zamarrón A, González S, Juarranz Á and Gilaberte Y: Combined
treatments with photodynamic therapy for non-melanoma skin cancer.
Int J Mol Sci. 16:25912–25933. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoon HE, Oh SH, Kim SA, Yoon JH and Ahn
SG: Pheophorbide a- mediated photodynamic therapy induces autophagy
and apoptosis via the activation of MAPKs in human skin cancer
cells. Oncol Rep. 31:137–144. 2014.PubMed/NCBI
|
|
6
|
Abbas M and Kalia S: Trends in
non-melanoma skin cancer (basal cell carcinoma and squamous cell
carcinoma) in Canada: A descriptive analysis of available data. J
Cutan Med Surg. 20:166–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hussain AA, Themstrup L, Nürnberg BM and
Jemec G: Adjunct use of optical coherence tomography increases the
detection of recurrent basal cell carcinoma over clinical and
dermoscopic examination alone. Photodiagn Photodyn Ther.
14:178–184. 2016. View Article : Google Scholar
|
|
8
|
Kauvar AN, Cronin T Jr, Roenigk R, Hruza G
and Bennett R: Consensus for nonmelanoma skin cancer treatment:
Basal cell carcinoma, including a cost analysis of treatment
methods. Dermatol Surg. 41:550–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cho E and Grim JE: A (heat) shocking
development: FBXW7 loss unleashes HSF1 to drive melanoma invasion
and metastasis. Pigment Cell Melanoma Res. 28:643–644. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Campione E, Paternò EJ, Candi E, Falconi
M, Costanza G, Diluvio L, Terrinoni A, Bianchi L and Orlandi A: The
relevance of piroxicam for the prevention and treatment of
nonmelanoma skin cancer and its precursors. Drug Des Devel Ther.
9:5843–5850. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang L, Yi XM, Chen J, Chen FJ, Lou W, Gao
YL, Zhou J, Su LN, Xu X, Lu JQ, et al: Ubiquitin ligase UBE3C
promotes melanoma progression by increasing epithelial-mesenchymal
transition in melanoma cells. Oncotarget. 7:15738–15746.
2016.PubMed/NCBI
|
|
12
|
Campos PM, Bentley MV Lopes Badra and
Torchilin VP: Nanopreparations for skin cancer
therapyNanobiomaterials in Cancer Therapy. Grumezescu AM: 7. 1st.
Elsevier; New York, NY: pp. 1–28. 2016, View Article : Google Scholar
|
|
13
|
Dummer R: Precision medicine and skin
cancer therapy: Dealing with a moving target. Curr Opin Oncol.
26:182–183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dixon AJ, Anderson SJ, Mazzurco JD and
Steinman HK: Novel photodynamic therapy does not prevent new skin
cancers - randomized controlled trial. Dermatol Surg. 40:412–419.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Na JI, Kim SY, Kim JH, Youn SW, Huh CH and
Park KC: Indole-3-acetic acid: A potential new photosensitizer for
photodynamic therapy of acne vulgaris. Lasers Surg Med. 43:200–205.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Valdes PA, Bekelis K, Harris BT, Wilson
BC, Leblond F, Kim A, Simmons NE, Erkmen K, Paulsen KD and Roberts
DW: 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in
meningioma: Qualitative and quantitative measurements in vivo.
Neurosurgery. 10 Suppl 1:74–83. 2014.PubMed/NCBI
|
|
17
|
Kanick SC, Davis SC, Zhao Y, Hasan T,
Maytin EV, Pogue BW and Chapman MS: Dual-channel red/blue
fluorescence dosimetry with broadband reflectance spectroscopic
correction measures protoporphyrin IX production during
photodynamic therapy of actinic keratosis. J Biomed Opt.
19:750022014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sidoroff A and Thaler P: Taking treatment
decisions in non-melanoma skin cancer - the place for topical
photodynamic therapy (PDT). Photodiagn Photodyn Ther. 7:24–32.
2010. View Article : Google Scholar
|
|
19
|
Huang C, Sun Z, Sun Y, Chen X, Zhu X, Fan
C, Liu B, Zhao Y and Zhang W: Association of increased ligand
cyclophilin A and receptor CD147 with hypoxia, angiogenesis,
metastasis and prognosis of tongue squamous cell carcinoma.
Histopathology. 60:793–803. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fei F, Li X, Xu L, Li D, Zhang Z, Guo X,
Yang H, Chen Z and Xing J: CD147-CD98hc complex contributes to poor
prognosis of non-small cell lung cancer patients through promoting
cell proliferation via the PI3K/Akt signaling pathway. Ann Surg
Oncol. 21:4359–4368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li L, Tang W, Wu X, Karnak D, Meng X,
Thompson R, Hao X, Li Y, Qiao XT, Lin J, et al: HAb18G/CD147
promotes pSTAT3-mediated pancreatic cancer development via CD44s.
Clin Cancer Res. 19:6703–6715. 2013. View Article : Google Scholar : PubMed/NCBI
|
